Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

Current Pharmaceutical Design - United Arab Emirates
doi 10.2174/138161208785294654
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Monoclonal Antibodies Targeting CD38 in Hematological Malignancies and Beyond

Immunological Reviews
AllergyImmunology
2016English

Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2011English

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies

Frontiers in Immunology
AllergyImmunology
2020English

A Novel Treatment Strategy Targeting Polo-Like Kinase 1 in Hematological Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Telomerase Activation in Hematological Malignancies

Genes
Genetics
2016English

Bridging the Gap in Hematological Malignancies

Expert Review of Hematology
Hematology
2012English

I(5)(p10) in Hematological Malignancies

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2019English

Advances in Immunotherapy for Hematological Malignancies

Journal of Nihon University Medical Association
2016English

Clonal Evolution in Hematological Malignancies and Therapeutic Implications

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy